The EURETINA meeting attracted over 11,000 attendees, showcasing advancements in retinal disease treatments, including gene therapy and implants for geographic atrophy. Gene therapy offers a potential ...

GLP-1 RAs may have an anti-inflammatory benefit, suggesting potential use in other ocular inflammatory diseases. Patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have roughly ...

One test of a nation-changing law is that it remains a centerpiece of American life and Washington’s pitched political fights long after the president responsible left office. Franklin Roosevelt’s New ...

An optical phenomenon known as a sun dog was spotted in the sky over several Connecticut towns on Tuesday afternoon. These colorful spots of light were visible in towns like Trumbull, Rocky Hill, ...

Learn how to login to Army email securely through webmail and official DoD portals. This guide explains the steps for desktop and mobile users, plus common login issues and fixes. Go to Army 365 ...

Lupin Ltd.'s subsidiary has finalised a deal to fully acquire Amsterdam-headquartered VISUfarma BV for 190 million euros, the company informed the exchanges on Monday. Lupin's share price gained ...

VISUfarma's established European operations will provide market expansion opportunities, direct presence and further business diversification across major European countries, including Italy, the UK, ...

A new biotechnology startup is launching with plans to challenge some of the world’s best-selling eye medicines, armed with a pair of prospects already in, or approaching, clinical testing. Called ...

Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...